This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe
1-3 December 2025
Mercure Hotel MOABerlin, Germany

Bo Wiinberg
Chief Business Development Officer at Novo Nordisk Foundation Cellerator
Speaker

Profile

Bo Wiinberg is an accomplished life sciences leader with extensive experience spanning academia, biotech, and the pharmaceutical industry. As Chief Business Development Officer at the Novo Nordisk Foundation Cellerator, he drives strategic partnerships and innovation initiatives to accelerate the development and manufacturing of advanced therapies.

Prior to joining the Cellerator, Bo served as Entrepreneur in Residence at the BioInnovation Institute, where he supported the creation and growth of academic spinouts and early-stage ventures. Earlier, he spent more than a decade at Novo Nordisk A/S in senior leadership roles—including Head of Cell Therapy Strategy & Operations—where he helped shape global R&D strategy and translate emerging science into therapeutic innovation.

Agenda Sessions

  • Funding the Future – Investor Panel Discussion: Investments in Cell and Gene Therapies and Enabling Technologies

    09:50